TrialJournal of diabetes science and technology2013

A novel insulin combination of insulin degludec and insulin aspart achieves a more stable overnight glucose profile than insulin glargine: results from continuous glucose monitoring in a proof-of-concept trial.

Andreas Liebl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.